Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Welcome to Startland News
Scrappy. Determined. Gritty. Those often were the words attributed to the Kansas City Royals as the team unexpectedly surged into the 2014 World Series and captured the national spotlight. Those very words are apt for this city, which has been built on the grit and determination of successful entrepreneurs like Ewing Kauffman, Joyce Hall, Henry…
Kansas budget woes render uncertainty for angel tax credits
As state budgetary concerns loom in the background, early-stage firms in Kansas are hoping a bill to extend the Sunflower State’s Angel Investor Tax Credit program will become a priority for legislators. Scheduled to sunset after the 2016 fiscal year, the program annually allocates $6 million in credits to entice investments in early-stage, growth-oriented companies…
KC virtual reality firm partners with KU, NFL coaches
A Kansas City-based virtual reality company hopes some marquee partnerships will plug it into a market projected to reach $150 billion in five years. Founded in 2013, Eon Sports VR recently landed the University of Kansas football team as a client for its mobile virtual reality platform to help players train without the risk of…
ECJC relocates office, updates brand
The Enterprise Center in Johnson County is shaking things up. The non-profit organization that connects entrepreneurs to the resources they need to grow revealed Thursday an updated website, brand identity, and new office location. “This move is the culmination of a long, strategic transition to ensure that as Kansas City’s entrepreneurial community changes, we change…